REG-Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026
Addex Therapeutics announced it will report 2026 half-year and second-quarter financial results on September 28, 2026, with a conference call and webcast at 16:00 CEST the same day. CEO Tim Dyer and Head of Translational Science Mikhail Kalinichev will provide a business update and pipeline review for investors, analysts and media.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.